These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34975257)

  • 1. Primary Breast Tumors with Mesenchymal Morphology.
    Tevatia MS; Mishra P; Baranwal AK; Nichat PB; Shelly D; Awasthi S; Sengupta P
    J Lab Physicians; 2021 Dec; 13(4):362-367. PubMed ID: 34975257
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
    Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
    Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions.
    Chen PH; Bossuyt V; Reisenbichler E
    Hum Pathol; 2021 Feb; 108():68-75. PubMed ID: 33245988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors.
    Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
    Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin mutations in 2 nested stromal epithelial tumors of the liver--a neoplasia with defective mesenchymal-epithelial transition.
    Assmann G; Kappler R; Zeindl-Eberhart E; Schmid I; Häberle B; Graeb C; Jung A; Müller-Höcker J
    Hum Pathol; 2012 Nov; 43(11):1815-27. PubMed ID: 22749188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM; Poryazova-Markova EG
    Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast.
    Feng X; Zhao L; Shen H; Liu X; Yang Y; Lv S; Niu Y
    Oncotarget; 2017 May; 8(20):33365-33374. PubMed ID: 28380418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
    Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
    Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of metaplastic breast carcinoma: FNAC; histopathology and immunohistochemistry are complementary for diagnosis.
    Abd El Hafez A; Shawky Ael-A
    Breast Dis; 2013 Jan; 34(2):67-75. PubMed ID: 24077354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.
    González-Martínez S; Pérez-Mies B; Pizarro D; Caniego-Casas T; Cortés J; Palacios J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
    Hennessy BT; Gonzalez-Angulo AM; Stemke-Hale K; Gilcrease MZ; Krishnamurthy S; Lee JS; Fridlyand J; Sahin A; Agarwal R; Joy C; Liu W; Stivers D; Baggerly K; Carey M; Lluch A; Monteagudo C; He X; Weigman V; Fan C; Palazzo J; Hortobagyi GN; Nolden LK; Wang NJ; Valero V; Gray JW; Perou CM; Mills GB
    Cancer Res; 2009 May; 69(10):4116-24. PubMed ID: 19435916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
    Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
    Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
    Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
    Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal transition in metaplastic breast carcinomas with chondroid differentiation: expression of the E-cadherin repressor Snail.
    Gwin K; Buell-Gutbrod R; Tretiakova M; Montag A
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):526-31. PubMed ID: 20697265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
    Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
    Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
    Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
    Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
    Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
    Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression.
    Jørgensen CLT; Forsare C; Bendahl PO; Falck AK; Fernö M; Lövgren K; Aaltonen K; Rydén L
    Breast Cancer Res Treat; 2020 Jun; 181(2):369-381. PubMed ID: 32300922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.